(): Signing the project entry agreement with the management committee of Fuyan Industrial Cooperation Park will help to further improve the company’s industrial layout.
China Fortune Link October 11-Baolixin announced that in order to further improve the company’s industrial layout and broaden the company’s lithium battery products, the company and the management Committee of Fuyan Industrial Cooperation Park signed the Agreement on the Entry of Baolixin Headquarters and PACK Factory Project and the Agreement on the Entry of Baolixin 6GWh Energy Storage Battery Green Factory Project. The company plans to invest in the establishment of Baolixin headquarters and PACK factory project (Phase I) and Baolixin 6GWh energy storage battery green factory project (implemented in two phases: Phase II and Phase III) in Fuyan Industrial Cooperation Park, and the management committee of Fuyan Industrial Cooperation Park gives the company full support in supporting services, policy subsidies, resources and capital introduction.
Hua Shengchang signed a tripartite supervision agreement on raising funds.
On October 11th, () announced that, according to the approval of the China Securities Regulatory Commission, the company publicly issued RMB ordinary shares on the Shenzhen Stock Exchange, with 33,333,400 shares issued at an issue price of RMB 1489 per share, with the total raised funds of RMB 496,334,300 and the actual net raised funds of RMB 454,266,400. The company and its subsidiaries signed a tripartite supervision agreement on raised funds with the deposit banks and sponsors, and opened a special account for raised funds.
Xinhongye plans to invest 37.5 million yuan in a new energy fund.
() Announcement, the company plans to invest in Wuxi Shanshui Green Energy Venture Capital Partnership (Limited Partnership) ("Investment Fund"). The scale of the investment fund is 150 million yuan, and the company has subscribed 37.5 million yuan with its own funds, accounting for 25% of the investment. It is reported that the fund mainly focuses on the "development, storage, delivery and use" of the new energy industry chain, focusing on investment in core components, manufacturing, equipment and materials related to zero carbon, green electricity and intellectual manufacturing. The main investment area of the fund is the Yangtze River Delta region.
Sande Technology: The purchased Zhongrong Trust products have the risk of overdue payment.
() Announcement: The company had previously purchased Gengze No.1 trust product with idle self-owned funds of RMB 10 million on March 21, 2023, and purchased Yuanrong No.1 trust product with idle self-owned funds of RMB 65 million on March 27, April 13 and July 7, 2023 respectively. The trustees of related products are Zhongrong International Trust Co., Ltd..
As of the disclosure date of this announcement, the company has not received the principal and investment income of the above trust plan; The company has communicated with Zhongrong Trust on the follow-up matters of overdue payment of the above trust plan, and as of the disclosure date of this announcement, it has not received its formal written reply. In view of the uncertainty in the recovery of the investment funds of the above trust products, and based on the nature of their non-principal-guaranteed wealth management products, there is a risk that the principal and interest cannot be fully paid or only partially paid.
Sande Technology: Some trust products are overdue.
On October 11th, Securities News Agency announced that Sande Technology issued a risk warning announcement. As of the disclosure date of this announcement, the balance of other wealth management products purchased by the company with idle self-owned funds that have not yet expired was 260 million yuan, all of which are low-and medium-risk products such as structured deposits and large deposit certificates of national state-owned joint-stock banks and securities companies. In view of the uncertainty in the recovery of the investment funds of the above trust products, and based on the nature of non-guaranteed wealth management products, there is a risk that the principal and interest cannot be fully paid or only partially paid, and the impact on the company’s current and future profits is also uncertain, which is subject to the company’s announcement.
Nastar has spent 174 million yuan to buy back 5,069,800 shares.
() It was announced that from May 30, 2023 to September 30, 2023, the company repurchased 5,069,800 shares through centralized bidding, accounting for 0.36% of the company’s total share capital, with a total payment of 174 million yuan.
Kaineng Health plans to spend 267 million yuan to increase its holding of the original energy group, and the next step is to plan and promote the IPO of the business segment.
On the evening of October 10th, () announced that the company planned to acquire 12.87% equity of the original energy group held by Shanghai Senlu and Shanghai Senba for 267 million yuan. After the acquisition is completed, the proportion of shares held by Kaineng Health in Yuanneng Group will increase from 23.65% to 36.52%. At the same time, Kaineng Health will increase the nomination right of directors to strengthen the decision-making influence on the original energy group.
According to public information, the original energy group was founded by Kaineng Health in July 2014 with a registered capital of 634 million yuan. Headquartered in the core area of Shanghai Zhangjiang Biomedical Industry Base, it is an important part of Kaineng’s healthy layout and large health industry development. Since its establishment, Yuanneng Group has included many core companies such as Haitai Pharmaceutical, Yuanneng Cell and Yuanqi Bio, among which, Yuanqi Bio and Yuanneng Bio have clear IPO listing plans.
Kaineng Health said that the transaction will not have a significant impact on the company’s financial situation and operating results in 2023. In the future, depending on the operation and assets of the original energy group, the company will not rule out further increasing or acquiring the equity of the original energy group held by other shareholders, or passively changing the shareholding ratio due to the withdrawal of other shareholders’ capital reduction.
Strengthen the layout and fit the strategy of "dual-energy drive"
Since its establishment in 2014, Kaineng Health, as the founding shareholder and the largest shareholder of Yuanneng Group, has promoted the core business of Yuanneng Group based on cell storage, and extended its upstream and downstream to cryogenic cell storage equipment, cell therapy applications, cell cosmetics applications, and medical industrial park business.
Up to now, the holding and shareholding companies of Yuanneng Group include six major parts, among which Haitai Pharmaceutical, Restoring Bio, Dongxin Bio, Yuanneng Cell Bank Co., Ltd., Yuanneng Cell (Lishui) Industry Development Co., Ltd., Shanghai Yuantian Biotechnology Co., Ltd., Jiyuan Meiye Biotechnology (Shanghai) Co., Ltd., Shanghai Yuanneng Cell Bio-Cryogenic Equipment Co., Ltd. and Yuanqi Bio-tech are the cores, gradually bearing the core technology development of the Group in different fields.
The person in charge of Kaineng Health told the Securities Daily reporter: "The transfer of the original energy group’s equity is mainly in line with the company’s’ dual-energy-driven’ strategy, and the cultivated upstream and downstream business of cell storage and the company’s existing water purification business will jointly build a healthy industrial chain for human settlements."
As a leading A-share whole house water purification enterprise, Kaineng Health has developed well in recent years. Under the severe external environment test in the past three years, the company has continuously achieved steady growth in performance. In the first half of this year, with the growth of gross profit of overseas orders and the elimination of external objective unfavorable factors in the same period of 2022, Kaineng achieved a healthy operating income of 796 million yuan, a year-on-year increase of 6.55%; The net profit attributable to shareholders of listed companies was 53.7822 million yuan, a year-on-year increase of 72.45%.
In the announcement, Kaineng Health said that through this equity acquisition, it will further strengthen the company’s strategic layout in the health field, enhance the company’s comprehensive competitiveness and sustainable development ability, continuously consolidate the company’s dominant position, and consolidate the basic base of the company’s main business, which is in line with the company’s development strategy.
"If this transaction can finally be implemented smoothly and the operation of the transaction target meets expectations, it will have a positive impact on the company’s future financial status and operating results." Kaineng health scale.
Develop well and plan for independent listing of business.
While practicing the strategy of "dual-energy drive", Kaineng Health has a very clear goal for the next development of Yuanneng Group.
The announcement shows that after nearly 10 years of development, the original energy group’s current industry situation and its own layout situation are very good, and it has been able to achieve breakeven, and it has gradually changed into cultivating the cell industry ecosystem. Under the guidance of the actual controller, the relevant business sectors will hire professional teams, and after the business model is mature, they can plan to go public independently and introduce PE funds to accelerate.
The relevant person in charge further stated that the original energy group has no overall IPO listing plan at present, and the subsidiaries of the original energy group will consider IPO listing in the next step.
Among the holding and shareholding companies of Yuanneng Group, Yuanqi Bio is the main cell therapy drug development company incubated by Yuanneng Group. Up to now, the company’s products targeting advanced liver cancer have obtained the approval of clinical trials registered in National Medical Products Administration IND, and two other products are under preparation for IND application. In February this year, Yuanqi Bio announced that it had completed the B1 round of financing of US$ 45 million. The existing shareholder lineup includes Qiming Venture Capital and Jianfa Emerging Investment.
In order to expand the investment in the technology platform construction and innovative product development process of Yuanqi Bio, Kaineng Health said that Yuanqi Bio has completed 100% red chip restructuring and plans to go public overseas in the future.
At the same time, another company under the original energy group, which is mainly engaged in the research and development and sales of cell cryogenic storage equipment, is also constantly introducing external investors, completing the A round of financing in May 2022, and will also consider independent IPO listing in the future.
In an interview with Securities Daily, a person in charge of R&D of a domestic pharmaceutical company said: "Gene and cell therapy is the third wave of new drug research and development, which has just emerged in China-it has entered the stage from R&D to product transformation, and may become the mainstream of the market after ten years. However, its growth rate is much faster than that of the traditional drug market, so at this time node, enterprises tend to increase research and development to meet market demand. "
According to Kaineng Health, in the future, other business segments of the original energy group will follow this path. Therefore, some investors are willing to continue to sink into the subordinate business sector to continue PE investment, and some early investors intend to withdraw from investment and realize their own funds.
It is worth mentioning that after the completion of the equity transfer, qu jianguo, the actual controller of Kaineng Health, holds a total of 50.73% of the equity of Yuanneng Group and is the actual controller of Yuanneng Group. If the IPO of the original energy group’s business segment goes smoothly, qu jianguo will welcome another listed company after Shenhua Industry and Kaineng Health.
[Company] "Pay equal attention to China and the West" to a higher level! () buspirone hydrochloride tablets were approved by the new production site of FDA.
Huasen Pharmaceutical announced that it had recently received a notice from the US Food and Drug Administration (hereinafter referred to as the "US FDA") on the approval of PAS(PriorApprovalSupplement) for the new pharmaceutical production site of buspirone hydrochloride tablets (ANDA#208972). The details are as follows:
Huasen Pharmaceutical said that receiving the approval notice from the US FDA PAS is conducive to enriching the company’s products in the field of mental nervous system. In the future, the company will actively expand the international market and further enhance the international influence of its products, which is expected to have a positive impact on the company’s long-term operating performance.
Panorama. com understands that buspirone hydrochloride tablets are mainly suitable for the management of anxiety disorder or the short-term relief of anxiety symptoms. They are national basic drugs and national medical insurance drugs. They are aromatic piperazine antianxiety drugs and 5-HT1A receptor agonists for the treatment of generalized anxiety disorder and other anxiety disorders. Because of its high specificity, and no obvious adverse reactions such as sedation, hypnosis, muscle relaxation and dependence or withdrawal, it has been widely used in the treatment of various anxiety disorders in psychiatry, and can also be used to treat the anxiety state associated with physical diseases, and has been recommended as a first-line treatment drug by Chinese and foreign guidelines for the treatment of anxiety disorders.
Previously, Huasen Pharmaceutical had an exclusive proprietary Chinese medicine Liuwei Anshen Capsule in the field of mental nervous system and gained market recognition with definite curative effect. It has been included in the "Guide to Clinical Diagnosis and Treatment of Mental Diseases with Integrated Traditional Chinese and Western Medicine" as a recommended drug for "non-organic insomnia", and its sales revenue in the first half of this year increased by more than 60% year-on-year.
In particular, the FDA of the United States is recognized as the most authoritative, strict and influential drug management and supervision institution in the world. In recent years, it has continuously improved the standards for drug approval and strengthened the supervision of drug production. This inspection indicates that the GMP management of Huasen Pharmaceutical (good manufacturing practice) has reached the international leading level, and has been standardized, programmed and standardized in strict accordance with cGMP specifications.
In the secondary market, today’s Huasen Pharmaceutical shares closed at a daily limit of 18.24 yuan/share.
Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of innovative chemical medicine "G201-Na Capsule" was approved.
() Announcement: On October 11th, 2023, the company received the Notice of Approval for Clinical Trials of the innovative chemical medicine "G201-Na Capsule" approved and issued by National Medical Products Administration, and the applied indication was hysteromyoma.
It is reported that this product is a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist. Through competitive binding with pituitary GnRH receptor, drugs can inhibit pituitary gonadal axis, reduce the production and release of endogenous luteinizing hormone (LH) and follicle stimulating hormone (FSH), and reduce the level of estrogen, thus treating estrogen-dependent related diseases.
Shaanxi Energy’s 22,502,300 restricted shares will be listed and circulated on October 16th.
() Announced that the restricted shares listed and circulated this time are the restricted shares placed offline for the first time by the company, and the number of shares is 22,502,300, accounting for 0.6% of the company’s total issued share capital. The restricted sale period is 6 months from the date of the company’s initial public offering and listing. This part of the restricted shares will be released on October 16, 2023 and listed for circulation.
Ouhao Group, the controlling shareholder of King Kong Photovoltaic, released 5 million shares.
() It was announced that Guangdong Ouhao Group Co., Ltd. (hereinafter referred to as "Ouhao Group"), the controlling shareholder of the company, released the pledge of 5 million shares of the company on October 10, 2023, accounting for 10.53% of its shares and 2.31% of the company’s total share capital.
Lianlong: Establish Lianlong R&D Company to meet the needs of future business development.
() Announced that in order to meet the needs of the company’s future business development, the company invested 1 million yuan with its own funds to set up Tianjin Lian ‘long Technology R&D Co., Ltd. ("Lian ‘long R&D"), a wholly-owned subsidiary in Huayuan Industrial Zone, Tianjin Binhai High-tech Zone. The implementation of this project is conducive to enhancing the company’s core competitiveness in various business fields of biochemistry and new materials, while enhancing the company’s comprehensive strength and enhancing the company’s market competitiveness and risk resistance.
() It has spent 80,745,200 yuan to buy back 4,756,700 shares, accounting for 1.05% of the total share capital.
Seiko Technology announced that as of October 11th, 2023, the company had repurchased 4,756,700 shares of the company by centralized bidding, accounting for 1.05% of the company’s total share capital, of which the highest transaction price was 17.30 yuan/share, the lowest transaction price was 16.65 yuan/share, and the total transaction amount was 80,745,200 yuan (excluding transaction costs).
The share repurchase ratio of Zhongchong reached 1.033%, costing 66.61 million yuan.
() Announcement: As of September 30, 2023, the company has repurchased 3,037,400 shares, accounting for 1.033% of the company’s current total share capital, with the highest transaction price of 24.27 yuan/share and the lowest transaction price of 20.02 yuan/share, involving a total transaction amount of 66,605,300 yuan (excluding transaction costs).
Novo Novo: No share repurchase has been conducted.
() Announcement. According to the relevant provisions of the Guidelines for Self-regulation of Listed Companies of Shenzhen Stock Exchange No.9-Share Repurchase, the company shall announce the progress of repurchase by the end of last month within the first three trading days of each month. As of September 30, 2023, the company has not carried out share repurchase.
Liu Huicheng, Chairman of Jinkong Power, resigned.
() Announced that the company received a written resignation report from Mr. Liu Huicheng, the chairman of the company today. Mr. Liu Huicheng resigned as a director, chairman of the 10th Board of Directors and chairman of the strategy committee of the Board of Directors due to job changes, and no longer held other positions in the Company and its subsidiaries after his resignation.
Baoding Technology’s 28.8522 million restricted shares will be listed and circulated on October 16th.
() Announcement: During the company’s major asset restructuring in 2022, some new shares purchased by issuing shares will be released from restricted sale, and the number of shares released this time is 28,852,200, accounting for 6.74% of the company’s total share capital; The listing date is Monday, October 16th, 2023.
Hongrun Construction won the bid for 892 million yuan urban rail transit civil construction project.
() Announcement, the company recently received the bid-winning notice from Hangzhou Metro Group Co., Ltd., and the SG18-7 bid section of the first phase of Hangzhou Urban Rail Transit Line 18 was won by the company, with a bid price of 892 million yuan.
The project includes Yongjiang Road Station, Yongjiang Road Station to Mo Xie Tangzhan Station, including bridge demolition and reconstruction, pipeline relocation and traffic diversion. The main contents are as follows: Yongjiang Road Station is a side station with three floors underground, with two entrances, four groups of wind pavilions, six emergency exits and one barrier-free elevator. The section from Yongjiang Road Station to Mo Xie Tang Station is a single circular shield tunnel, with four communication passages.
Lv Gang, the controlling shareholder of Jingxin Pharmaceutical, released 16.8 million shares.
() Announcement was issued. On October 10, 2023, the controlling shareholder of the company, Lu Gang, released the pledge of 16.8 million shares of the company, accounting for 9.40% of its shares and 1.95% of the company’s total share capital.
The cumulative repurchase of 3,472,700 shares in the Soviet trial cost 65,445,000 yuan.
() Announcement: As of September 28, 2023, the company repurchased 3,472,700 shares by centralized bidding, accounting for 0.68% of the company’s total share capital, with a total turnover of 65,445,000 yuan (excluding transaction costs).
Jingu shares received the designated notice of Avatar New Energy Vehicle.
() Announced that the company recently received a designated notice from a well-known new energy vehicle main engine factory (whose name cannot be disclosed due to confidentiality requirements, hereinafter referred to as the "customer"). The company will be the supplier of the customer to develop Avatar low-carbon wheel products for one of its main new energy vehicles, and the company will complete the product development and delivery according to the customer’s requirements.
Zhang Xiaoquan: The controlling shareholder pledges part of the shares.
On October 11th, () announced that the company recently received a notice from Zhang Xiaoquan Group, the controlling shareholder of the company, that Zhang Xiaoquan Group had pledged some of its shares, and the number of the pledged shares was 3,000,000, accounting for 3.95% of its shares and 1.92% of the company’s total share capital. As of the disclosure date of the announcement, Zhang Xiaoquan Group pledged 75,926,291 shares, accounting for 99.90% of its shares.
The controlling shareholder and actual controller of Jingu shares received a warning letter from Zhejiang Securities Regulatory Bureau.
Jingu Co., Ltd. issued an announcement. On October 10, 2023, Mr. Sun Fengfeng, Mr. Sun Jinguo and Ms. Sun Liqun, the controlling shareholders and actual controllers of the company, received the Decision on Taking Measures to Issue Warning Letters to Sun Fengfeng, Sun Jinguo and Sun Liqun issued by Zhejiang Supervision Bureau of China Securities Regulatory Commission. The details are as follows:
Upon investigation, the above-mentioned personnel, as the controlling shareholder and actual controller of Zhejiang Jingu Co., Ltd. (hereinafter referred to as Jingu Co., Ltd.), respectively signed relevant agreements with the subscribers of Jiutai Fund Management Co., Ltd. and other non-public offering shares during the non-public offering of shares of Jingu Co., Ltd. in 2017, and agreed to guarantee their bottom income. The above acts violate Article 17 of the Measures for the Administration of Securities Issuance and Underwriting (Order No.121 of the CSRC) and Article 2 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of the CSRC).
According to Article 38 of the Measures for the Administration of Securities Issuance and Underwriting (Order No.121 of the CSRC) and Article 59 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of the CSRC), Zhejiang Securities Regulatory Bureau decided to issue warning letters to Sun Fengfeng, Sun Jinguo and Sun Liqun respectively, and record them in the integrity files of the securities and futures markets.
Watson biological has spent 72.198 million yuan to buy back 2 million shares.
() Announcement was issued. As of September 30, 2023, the number of shares repurchased by the share repurchase company through the special securities account was 2 million shares, accounting for 0.12% of the company’s total share capital. The highest transaction price was 36.28 yuan/share, the lowest transaction price was 35.69 yuan/share, and the total transaction amount was 72.198 million yuan.
Yiwei lithium can buy back 2,087,400 shares at a cost of 100 million yuan.
() Announcement: As of September 30, 2023, the company has repurchased 2,087,400 shares by centralized bidding, accounting for 0.10% of the company’s total share capital, with a total turnover of 100 million yuan (excluding transaction costs).
Hongrun Construction: Won the bid of 892 million yuan for the civil construction project of Hangzhou rail transit project.
Hongrun Construction announced on the evening of October 11th that the company recently received the bid-winning notice from Hangzhou Metro Group Co., Ltd., and the SG18-7 bid section of the first phase of Hangzhou Urban Rail Transit Line 18 was won by the company. The bid price in the project was about 892 million yuan, accounting for 10.26% of the company’s annual operating income in 2022, and the construction period was 157 days.
Guangdian Express intends to list and transfer 51% equity of Huitong Jinke to withdraw funds and focus on its main business.
() Announced that since the acquisition, Huitong Jinke’s performance has continuously failed to meet expectations, and its business is less related to the company’s artificial intelligence high-tech main business. In order to withdraw funds and better focus on its main business, the company plans to publicly list and transfer its 51% equity of Huitong Jinke. Based on the evaluation results, the unit price of this listing and transfer of Huitong Jinke is not less than 3.48 yuan/share, and the total listing and transfer price is not less than 181 million yuan. The final transaction price is subject to the delisting price in Guangzhou Property Rights Exchange. After the completion of this equity transfer, the company no longer holds the equity of Huitong Jinke.
Guangdian Express: It is planned to transfer 51% equity of Huitong Jinke by listing at no less than RMB 181 million.
Guangdian Express announced on the evening of October 11th that the company intends to publicly list and transfer 51% equity of Huitong Jinke (stock code: 833631) with a total transfer price of not less than 181 million yuan. After the transfer, it will no longer hold the equity of Huitong Jinke. Guangdian Express said that since the acquisition in 2016, Huitong Jinke’s performance has continuously failed to meet expectations, and its business has little correlation with the company’s artificial intelligence high-tech main business. In order to withdraw funds and better focus on the main business, the company intends to transfer its equity. In addition, in order to focus on the development of its main business, the company plans to transfer 72% equity of Guangzhou Digital Finance Innovation Research Institute Co., Ltd. to Guangzhou Radio Group Co., Ltd. at a transfer price of 18 million yuan.
Yangjie Technology has spent 59.96 million yuan to buy back 1,668,500 shares.
() Announcement was issued. As of September 30, 2023, the company repurchased 1,668,500 shares of the company by centralized bidding through the special securities account, accounting for 0.3082% of the company’s current total share capital. The highest transaction price was 37.00 yuan/share, the lowest transaction price was 34.43 yuan/share, and the total transaction amount was 59.96 million yuan.
Gu Shuchun, director and deputy general manager of Sino-British Technology, completed the reduction and accumulated a reduction of 78,700 shares.
() Announcement: Gu Shuchun, the company’s director and deputy general manager, has completed the implementation of the share change plan, and he has reduced the company’s shares by 78,700 shares.
Everbright Tongchuang sent 3.5 yuan date of record for every 10 shares in the first half of 2023 as October 17th.
() Announced, the contents of the company’s equity distribution implementation plan for the first half of 2023 are as follows: based on the total share capital of 76 million shares, a cash dividend of RMB 3.50 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 26.6 million will be distributed, accounting for 49.75% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is October 17th, and the ex-dividend date is October 18th.
According to the 2023 semi-annual performance report released by Everbright Tongchuang, the company’s operating income was 427 million yuan, down 14.43% year-on-year; The net profit attributable to shareholders of listed companies was 53.4655 million yuan, a year-on-year decrease of 6.87%; The basic earnings per share was 0.84 yuan, compared with 1.01 yuan in the same period last year.
The main business of Shenzhen Guangdatong Innovative Materials Co., Ltd. is the research and development, production and sales of protective and functional products for consumer electronics. The company’s main products are consumer electronic protective products and consumer electronic functional products. The company’s customers are mainly consumer electronics terminal brands, manufacturing service providers and component manufacturers. After years of development, the company has become one of the enterprises with strong competitive advantages in the industry, with high-quality customer resources including Lenovo Group, (), (), Compal Computer, Wistron Zitong and Heshuo Technology. By the end of the reporting period, the company and its wholly-owned and holding subsidiaries had 149 patents, including 18 invention patents, 128 utility model patents and 3 appearance patents.
(Source: () iFinD)
Hong Zhipeng, the specific shareholder of Jindun Co., Ltd., has reduced its holdings by 4.975 million shares.
() Announcement: The term of the company’s specific shareholder Hong Zhipeng’s share change plan expires, and it changed 4.975 million shares by centralized bidding from March 2023 to September 2023.
Everbright tongchuang plans to send 10 shares to 3.5 yuan for ex-dividend on October 18th.
Everbright Tongchuang announced that the company’s half-year equity distribution in 2023 is planned to: distribute 3.5 yuan (including tax) to every 10 shares of all shareholders; Ex-dividend date: October 18, 2023.
Gansu Nenghua plans to increase the capital of Jingmei Company, a wholly-owned subsidiary, with the assets of Jingyuan Mining Area.
() Announce that the company intends to increase the capital of Gansu Jingmei Energy Co., Ltd. (hereinafter referred to as "Jingmei Company"), a wholly-owned subsidiary, with the legally owned assets of Jingyuan Mining Area, including major monetary funds, physical assets, stock rights, state-owned land use rights, mining rights and corresponding creditor’s rights and debts.
Gansu Nenghua: Jintai Testing, a subsidiary company, intends to acquire the equity of Jingzheng Testing and absorb and merge it.
Gansu Nenghua announced that in order to make full use of and activate the existing resources, realize the optimal allocation of resources and efficient utilization of assets, and promote the structural transformation and high-quality development of the company’s testing business, Gansu Jingzheng Construction Engineering Quality Testing Co., Ltd. (hereinafter referred to as "Jingzheng Testing") held by Gansu Kebede Coal and CBM Development Technology Co., Ltd. (hereinafter referred to as "Kebede", a third-level wholly-owned subsidiary of the company), 100% equity of the company’s fourth-level wholly-owned subsidiary was transferred to Lanzhou Jintai Inspection Technology Co., Ltd. (hereinafter referred to as "Jintai Inspection", a third-level wholly-owned subsidiary of the company) free of charge. After the equity transfer is completed, according to the actual operation situation, Jintai Inspection will absorb and merge with Precision Inspection.
After the completion of the equity transfer and merger, the legal entity qualification of Jingzheng Testing Company will be cancelled, and all its assets, liabilities, rights and interests and all other rights and obligations will be inherited by Jintai Testing Company.
Wang Junfang, director of Shengtian Network, completed the reduction of 86,500 shares.
() Announcement: Wang Junfang, the company’s director and senior manager, completed the implementation of the equity change plan and reduced the company’s shares by 86,500 shares.
Yantai Zhongxing, the controlling shareholder of Zhongchong Co., Ltd., and its concerted actions reduced their holdings by 770,000 pieces.
Zhongchong Co., Ltd. announced that the company recently received a letter from Yantai Zhongxing Biotechnology Co., Ltd. (hereinafter referred to as "Yantai Zhongxing"), and learned that Yantai Zhongxing and its concerted actors reduced their holdings of 27,700 "Zhongchong Zhuan" by block trading from May 8, 2023 to October 11, 2023, accounting for 10.01% of the total issuance.
The first phase of the new high-efficiency battery project with an annual output of 12GW of Hengdian Dongci subsidiary was put into operation.
() Announced that at present, the first phase of the 6GW new high-efficiency battery production line of the subsidiary’s annual output of 12GW new high-efficiency battery project has been completed and gradually put into production.
Jingyi Co., Ltd. signed a framework purchase contract with Huasheng Industry to purchase electrolytic copper from it.
() It was announced that the Company and its subsidiaries and Sun Company (hereinafter referred to as "subsidiaries") within the scope of consolidated statements signed a Framework Purchase Contract with Shenzhen Huasheng Industrial Co., Ltd. ("Huasheng Industrial") in 2023, stipulating that the Company and its subsidiaries would purchase electrolytic copper from Huasheng Industrial, and the validity period of the contract was from January 1, 2023 to December 31, 2023. The above contract did not stipulate the contract amount.
From January 1, 2023 to October 7, 2023, the amount of daily business contracts signed by the company and its subsidiaries with Huasheng Industry has accumulated to 1.205 billion yuan, accounting for 52.63% of the company’s total audited assets in 2022.
Since February this year, Liu Hui, the chairman of Jinkong Power, resigned due to work changes.
On the afternoon of October 11th, Jinkong Electric Power (SZ000767, share price of 3.12 yuan, market value of 9.6 billion yuan) announced that Chairman Liu Hui had resigned as a director, chairman and chairman of the strategy committee of the 10th Board of Directors of the Company due to "work change", and would no longer hold other positions in the Company and its subsidiaries after his resignation.
On February 22, 2023, Liu Huicheng was just elected as the chairman of Jinkong Power, and his tenure has been less than 8 months.
Jinkong Power announced that Liu Huicheng did not hold the company’s shares, and he was not the person who broke the trust. "The company will complete the follow-up work such as the addition of directors and the election of the chairman as soon as possible in accordance with legal procedures."
Liu Huicheng was born in May 1965. He used to be the Party Secretary and General Manager of Shanxi () Co., Ltd.; Member of the Party Committee and Deputy General Manager of Shanxi International Electric Power Group Co., Ltd.; Deputy General Manager, Standing Committee of Party Committee and Chairman of Trade Union of Jinneng Group Co., Ltd.; Deputy Secretary, Vice Chairman and General Manager of the Party Committee of Jinneng Holding Power Group Co., Ltd..
Jinkong Electric Power, formerly known as Shanxi Zhangze Electric Power Co., Ltd., was listed on the Shenzhen Stock Exchange in June 1997. Power generation and heat are the main businesses of Jinkong Power. In the first half of 2023, the company completed the power generation of 21.222 billion kWh and the heat supply of 21.9736 million Ji Jiao.
The semi-annual report of Jinkong Power in 2023 shows that the company achieved operating income of 10.295 billion yuan in the current period, up 10.45% year-on-year; The net profit attributable to shareholders of listed companies was 24,654,700 yuan, a year-on-year increase of 24.87%; The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 12.372 million yuan, a year-on-year increase of 173.48%, compared with a loss of 16.8364 million yuan in the same period of last year.
On the other hand, the net cash flow generated by Jinkong Power’s current operating activities was-820 million yuan, down 239.68% year-on-year. The company explained that it was "mainly due to the increase in cash paid for goods and services during the reporting period."
Yiling Pharmaceutical Co., Ltd.: The innovative drug G201-Na Capsule was approved for clinical trial, and its indication was hysteromyoma.
On October 11th, Yiling Pharmaceutical announced that the company received the Notice of Approval for Clinical Trials of Drugs approved and issued by National Medical Products Administration on the same day, and the application for clinical trials of innovative drug G201-Na capsule met the relevant requirements of drug registration, and agreed to carry out clinical trials, and the application indication was hysteromyoma.
According to the announcement, G201-Na is a new class 1 chemical drug developed by the company, and it is a new non-peptide oral small molecule GnRH receptor antagonist. In April, 2023, the company’s application for clinical trial of G201-Na capsule "Prostate cancer drug requiring androgen castration treatment" was approved by National Medical Products Administration. At present, this clinical trial is in progress.
(Shenzhen Stock Exchange)
Joy City: One new real estate project was added in the third quarter.
() Announced that in the third quarter of 2023, the company added one new project. It is plot hk367-01 of North Bund Street, Hongkou District, Shanghai. The project is located in North Bund Street, Hongkou District, Shanghai, west of Baoding Road and north of Kunming Road. The land transfer area of this plot is 23,849.20 square meters, with a floor area of no more than 46,505.94 square meters, and the land use is residential land. The project was acquired through the open market equity acquisition of Shanghai Equity Exchange, and the price to be paid was about RMB 1.2 billion (the equity consideration was RMB 1.196 billion and the principal of creditor’s rights was RMB 4 million). Joy City Real Estate Co., Ltd., a holding subsidiary of the company, holds 100% rights and interests of the project.
[Company] When Dio Home newly obtained two invention patents and its single-quarter operating performance improved,
() It was announced that the subsidiary company had recently obtained two invention patent certificates issued by China National Intellectual Property Administration, the patent names of which were "A light glazed tile made of coal cinder and its preparation method" and "Cobalt-free black glaze and cobalt-free black glaze ceramics and their preparation method".
Founded in 1994, Dio Home Furnishing Group Co., Ltd. is an enterprise specializing in the production of high-quality sanitary ware, and its brand is well-known at home and abroad. Products cover bathroom cabinets, toilets, bathtubs, showers, shower rooms, faucets and other all-round quality products. In 2016, imperial ware A-shares went public, and successfully joined hands with the well-known domestic ceramic enterprise Ou Shennuo to establish Dio Home Furnishing Co., Ltd., which officially entered the pan-home field.
According to the semi-annual report disclosed by the company, in the first half of 2023, the company achieved revenue of 1.775 billion yuan, including ceramic tile income of 1.449 billion yuan and bathroom business income of 271 million yuan. Quarterly, the company’s performance improved significantly in the second quarter of this year, with operating income of 1.165 billion yuan in a single quarter reaching a new high in the last four quarters, nearly doubling that in the first quarter. The net profit attributable to the mother and the net profit after deduction turned from negative to positive, greatly improving year-on-year and quarter-on-quarter.
Over the rainbow shares: Wulong Company reduced its shareholding by 2.8%, and the shareholding reduction expired.
() Announcement was issued. As of October 10, 2023, the time limit of Wulong Company’s reduction plan has expired, and its total reduction is 32,655,700 shares, with a reduction ratio of 2.80%.
Tianyin Electromechanical Co., Ltd. was reduced by 4,250,300 shares by shareholder Tianheng Investment.
() Announcement: Recently, the company received the Notice Letter on the Change of Share Equity to 1% issued by Changshu Tianheng Investment Management Co., Ltd. (hereinafter referred to as "Tianheng Investment") and its concerted actors Zhao Yunwen and Changshu Hengtai Investment Co., Ltd. Tianheng Investment reduced its holdings of 4,250,300 shares from July 10, 2023 to October 9, 2023.
Distribution of half-year rights and interests of Lingyizhi: 0.3 yuan and date of record will be distributed for every 10 shares on October 18th.
() Announced that the company’s equity distribution plan for the first half of 2023 is: based on the existing total share capital of the company excluding the repurchased shares, 0.3 yuan RMB cash (including tax) will be distributed to all shareholders for every 10 shares. The date of record for this equity distribution is October 18, 2023, and the ex-dividend date is October 19, 2023.
Saimo Intelligent and Good Luck United signed a strategic cooperation framework agreement on building a digital mine.
() Announced that the company and Fujian Haoyunlian Information Technology Co., Ltd. ("Haoyunlian") recently signed the Strategic Cooperation Framework Agreement, and the two parties intend to jointly build and optimize green and intelligent digital mines, digital logistics and digital enterprises and other related services and products.
This time, the two sides intend to cooperate in top-level planning, design, scientific research, technology and standardization of open-pit smart mines, and jointly create smart mine solutions including open-pit new energy transportation systems, such as jointly establishing a "5G+ open-pit new energy transportation" demonstration project; Planning to realize the digitalization of the whole mining area and continuous low-carbon production in the open air; Jointly study the digital operation and maintenance management norms of smart mines; Promote the construction of new energy transportation system in open pit mines.
Within the scope of cooperation, the two sides established an agreement on information sharing, and market information should be reported to each other, so as to jointly expand the business of new energy mining vehicles and heavy trucks in open pit mines and expand their common market share.
According to the announcement, the signing of this strategic cooperation framework agreement is in line with the company’s future strategic development plan. In the next step, based on its own ecological resources advantages in the field of intelligent manufacturing, the company will develop and promote key core products and technical solutions for electrification of mining cards and construction machinery and equipment, green electricity transportation and green digital transformation of logistics and transportation for selected scenarios, further enhancing the company’s core competitiveness in the field of smart energy.
Xintian Technology repurchased 14,696,500 shares at a cost of 50,201,300 yuan.
() Announcement: As of September 30, 2023, the company has repurchased 14,696,500 shares, accounting for 1.26% of the company’s total share capital. The total transaction amount is 50,201,300 yuan (excluding transaction costs).
Longquan Co., Ltd. subsidiary pre-won the bid of 45.797 million yuan for related bidding and procurement projects.
() Announcement: Recently, CNNC (Shanghai) Supply Chain Management Co., Ltd., a tendering agency, issued a public notice on the e-procurement platform of China National Nuclear Corporation, and determined that Wuxi Xinfeng Pipe Industry Co., Ltd. ("Xinfeng Pipe Industry"), a wholly-owned subsidiary of the company, was the first successful candidate for "Zhangzhou 34, Sanmen56, Jindian Project, Jiangsu Green Energy Project RCC-M2, Grade 3 Carbon Steel Pipe Fittings and Equipment Procurement Bid Section II". The tender offer is RMB 45.797 million, accounting for about 4.60% of the company’s audited operating income in 2022.
Ruichen Environmental granted 1.017 million restricted shares at a price of 14.93 yuan per share.
() Announcement: The conditions for the first grant of restricted shares stipulated in the Company’s Restricted Stock Incentive Plan 2023 (Draft) have been achieved, and October 11, 2023 is determined as the first grant date, and 1,017,000 restricted shares will be granted to 30 incentive targets at the grant price of 14.93 yuan/share.
Sunflower Pharmaceutical: Ibuprofen Suspension Drops were accepted by the marketing license.
() Announcement: Harbin Sunflower Pharmaceutical Co., Ltd. (hereinafter referred to as "Harbin Sunflower"), a wholly-owned subsidiary of the company, recently received the Notice of Acceptance on the application for registration and marketing license of ibuprofen suspension drops issued by National Medical Products Administration. The drug is suitable for reducing fever in infants and children and relieving mild headache, sore throat and toothache caused by colds and flu.
Jianfan Bio bought back 5,958,200 shares at a cost of 133 million yuan.
() Announcement: As of September 28, 2023, the company has repurchased 5,958,200 shares, accounting for 0.74% of the company’s total share capital, with a turnover of 133 million yuan (excluding transaction costs).
Jinhe Industrial repurchased 4,352,800 shares at a cost of more than 100 million yuan.
() Announcement: As of September 30, 2023, the company has repurchased 4,352,800 shares, accounting for 0.78% of the company’s current total share capital. The highest transaction price is 25.10 yuan/share, the lowest transaction price is 21.45 yuan/share, and the transaction amount exceeds 100 million yuan (excluding transaction costs).
Saide Investment, the controlling shareholder of Qidi Design, intends to terminate the transfer of the agreement.
() Announcement: Suzhou Side Investment Management Co., Ltd. (hereinafter referred to as "Side Investment"), the controlling shareholder of the company, intends to terminate the agreement with Zhongneng Huaan (Beijing) New Energy Technology Co., Ltd. (hereinafter referred to as "Zhongneng Huaan") to transfer the company’s shares (involving 34,777,500 shares).
Leading Yizhi made every 10 shares in the first half of 2023 and sent 0.3 yuan date of record as October 18th.
Ling Yizhou announced that the company’s half-year equity distribution implementation plan for 2023 is as follows: based on the total share capital of 6,990,533,700 shares, a cash dividend of 0.30 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 210 million yuan will be distributed, accounting for 16.8% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is October 18th, and the ex-dividend date is October 19th.
According to the semi-annual performance report released by Lingyizhi in 2023, the company’s operating income was 15.289 billion yuan, a year-on-year increase of 3.27%; The net profit attributable to shareholders of listed companies was 1.248 billion yuan, a year-on-year increase of 159.29%; The basic earnings per share was 0.18 yuan, compared with 0.07 yuan in the same period last year.
Guangdong Lingyizhi Manufacturing Co., Ltd. (formerly known as Guangdong Jiangfen Magnetic Materials Co., Ltd.) is mainly engaged in the production and sales of new electronic components, mobile phones and computer accessories. The main products are divided into five categories: die-cutting products, CNC products, stamping parts, fasteners and assembly products.
(Source: Straight Flush iFinD)
Pulit: Announcing the progress of share repurchase
On the evening of October 11th, Shanghai () Composite Materials Co., Ltd. announced that by September 30th, 2023, the company had repurchased 5,287,100 shares by centralized bidding through the special securities account for share repurchase, accounting for 0.47% of the company’s total share capital. The highest transaction price was 14.18 yuan/share, the lowest transaction price was 12.66 yuan/share, and the total transaction amount paid was 70 yuan. The source of funds for the repurchase of shares is the company’s own funds, and the progress of the repurchase conforms to the requirements of laws and regulations and the repurchase plan. The company will continue to implement the repurchase plan and fulfill its information disclosure obligations as required.
Zhongmi Holdings sends 5 yuan date of record for every 10 shares in half a year on October 19th.
() It is announced that the company will distribute the rights and interests in the first half of 2023, and distribute 5 yuan and date of record to all shareholders for every 10 shares on October 19th.
Gan Consulting’s subsidiary won the bid of 10.95 million yuan for related engineering survey and design projects.
() Announced that Gansu Water Resources and Hydropower Survey and Design Institute Co., Ltd. ("Hydropower Design Institute"), a wholly-owned subsidiary of the company, recently received the bid-winning notice of "Survey and Design of High Efficiency Agricultural Irrigation Water Source Project in the North of Pingchuan District, Baiyin City, Gansu Province", and the bid-winning price was 10.95 million yuan.
Haiyi Investment, the major shareholder of Hongxin Electronics, reduced its holdings by 4,884,100 shares, accounting for 1% of the total share capital.
() It was announced that Xiamen Haiyi Investment Co., Ltd. (hereinafter referred to as "Haiyi Investment"), a shareholder holding more than 5% of the company’s shares, has reduced its holdings by a total of 4,884,100 shares, accounting for 1% of the company’s total share capital, with a reduction amount of 90,058,300 yuan.
Sunflower Pharmaceutical: The application for marketing license of ibuprofen suspension drops was accepted.
Sunflower Pharmaceutical announced on the evening of October 11th that Harbin Sunflower Pharmaceutical, a wholly-owned subsidiary, recently received the Notice of Acceptance issued by National Medical Products Administration on the application for registration and marketing license of ibuprofen suspension drops. Ibuprofen suspension drops are suitable for infants to reduce fever and relieve mild headache, sore throat and toothache caused by colds and flu.
Saimo Intelligent: Signed a strategic cooperation framework agreement with Good Luck Lianlian Information Company.
Saimo Intelligent announced on the evening of October 11th that the company and Fujian Haoyunlian Information Technology Co., Ltd. recently signed a strategic cooperation framework agreement, and the two parties intend to jointly build and optimize green and intelligent digital mines, digital logistics and digital enterprises and other related services and products.
Zhongmi Holdings will send 5 yuan date of record for every 10 shares in the first half of 2023 on October 19th.
Zhongmi Holdings announced that the company’s half-year equity distribution implementation plan for 2023 is as follows: based on the total share capital of 205,352,600 shares, a cash dividend of 5.00 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 103 million yuan will be distributed, accounting for 63.73% of the net profit attributable to the mother in the same period. No bonus shares will be distributed and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is October 19th, and the ex-dividend date is October 20th.
According to the 2023 semi-annual performance report released by Zhongmi Holdings, the company’s operating income was 613 million yuan, a year-on-year increase of 6.94%; The net profit attributable to shareholders of listed companies was 161 million yuan, a year-on-year increase of 6.92%; The basic earnings per share was 0.79 yuan, compared with 0.73 yuan in the same period last year.
Zhongmi Holding Co., Ltd. is mainly engaged in the design, research and development, manufacture and sales of various mechanical seals and their auxiliary (control) systems, and provides customers with all-round technical services such as technical consultation, technical training, on-site installation and maintenance. The company’s main products are mechanical seals, dry gas seals, rubber seals, mechanical seal auxiliary systems, seal product repair, spare parts and special valves. The company has cooperated with Sinopec, PetroChina, CNOOC, National Petroleum and Natural Gas Pipeline Network Group, National Energy Group, China () Group, China National Nuclear Corporation, China Guangdong Nuclear Power Group, () Group, China Communications Construction Group, Wanhua Group, Hengyi Group, Sany Group, as well as famous domestic and foreign OEMs Siemens, Shengu Group, Shaanxi Drum Group, Sulzer, Jia Park Jung Su Renyuan, Dalian Deep Blue and Beijing.
(Source: Straight Flush iFinD)
Longquan Co., Ltd.: The subsidiary won the bid of 45,796,700 yuan for the procurement of carbon steel pipe fittings and equipment.
Longquan announced on the evening of October 11th that recently, Wuxi Xinfeng Pipe Industry Co., Ltd., a wholly-owned subsidiary of the company, was the first candidate to win the bid for "Zhangzhou 34, Sanmen 56, Jindian Project, Jiangsu Green Energy Project RCC-M2, Grade 3 Carbon Steel Pipe Fittings and Equipment Procurement Bid Section II", and the bid price was about 45.7967 million yuan, accounting for 4.6% of the company’s annual operating income in 2022.
Yantian Port: The reorganization will be held in the near future.
() Announcement, the company intends to purchase 100% equity of Shenzhen Yangang Port Operation Co., Ltd. from Shenzhen Port Group Co., Ltd. by issuing shares and paying cash, and raise matching funds.
After the merger, acquisition and reorganization review committee of Shenzhen Stock Exchange has completed the relevant matters, it plans to review the issue of shares and the payment of cash to purchase assets and raise matching funds in the near future.
Tianbang Food: Zhang Banghui, the controlling shareholder, handles the equity pledge.
Securities Daily News On the evening of October 11th, () announced that Tianbang Food Co., Ltd. recently received a notice from Zhang Banghui, the controlling shareholder of the company (currently holding 369,700,885 shares of the company’s tradable shares, accounting for 20.10% of the company’s total share capital, including 301,301,614 shares with restricted sales conditions) about handling the equity pledge. The pledged shares are 10 million shares, accounting for 2.70% of its shares and 0.54% of the company’s total share capital. The start date of pledge is October 10, 2023, and the end date of pledge is until the pledgee handles the cancellation of pledge with China Securities Depository and Clearing Co., Ltd.
Zhenhua Technology: Use some idle raised funds for cash management.
On the evening of October 11th, () announced that China Zhenhua (Group) Technology Co., Ltd., at the 18th meeting of the 9th Board of Directors and 13th meeting of the 9th Board of Supervisors held on October 11th, 2023, deliberated and passed the Proposal on Using Part of Idle Raised Funds for Cash Management, and agreed that the company should use no more than 210 yuan without affecting the normal construction of raised funds investment projects and the raised funds investment plan.
Accelerating the Internationalization Layout Guoxuan Hi-Tech plans to build a lithium battery production line in Illinois, USA.
() Announcement, the company plans to build a lithium battery project in Illinois, USA, and entrusts a wholly-owned subsidiary, American Guoxuan, to sign relevant agreements with the Illinois government and other third parties. Source of funds: Cooperation and joint investment with third-party strategic investors. American Guoxuan signed the REV TAX CREDIT AGREEMENT with the Illinois government. The main content of the agreement is: Illinois will give tax subsidies to this project based on the REV Subsidy Act that was previously passed to subsidize new energy and tram enterprises.
It is reported that the project aims to meet the growing demand of the new energy power and energy storage battery market in North America, deepen the cooperative relationship with long-term strategic customers, quickly realize the localized manufacturing capability, and further improve the company’s international layout. The project will focus on the battery manufacturing business, and at the same time realize local independent supply in conjunction with raw material suppliers in the region to meet the company’s future business development and market expansion needs.
Gan Consulting: The subsidiary won the bid for the engineering survey and design project of 10.95 million yuan.
Gan Consulting announced on the evening of October 11th that Gansu Provincial Water Resources and Hydropower Survey and Design Institute Co., Ltd., a wholly-owned subsidiary, recently received the bid-winning notice for the project "Survey and Design of High Efficiency Agricultural Irrigation Water Source Project in the North of Pingchuan District, Baiyin City, Gansu Province", with a bid price of 10.95 million yuan.
Gaoxinxing Chuanglian, a subsidiary of Gaoxinxing Holdings, intends to apply for listing on the New Third Board.
() Announcement: The Board of Directors and the Board of Supervisors of the Company reviewed and approved the Proposal on the Holding Subsidiary’s Application for Listing on the New Third Board, and agreed that Gaoxin Chuanglian, the holding subsidiary of the Company, applied for listing on the New Third Board.
According to the announcement, Gaoxin Chuanglian is the core supplier of domestic railway rail transit industry, mainly engaged in railway train control, communication, video and Internet of Things and other related businesses.
According to the announcement, this application for listing on the New Third Board will be conducive to further improving the corporate governance structure and standardized operation of Gaoxin Chuanglian, enhancing brand influence and enhancing core competitiveness.
Guoxuan Hi-Tech: It is planned to build a lithium battery project in Illinois, USA.
Guoxuan Hi-Tech announced on the evening of October 11th that in order to seize the development opportunity of North American new energy market, the company plans to invest in the construction of lithium battery production line project in Illinois, USA, and the specific amount will be determined according to the feasibility analysis and application and approval of the project. The company intends to entrust Gotion,Inc, a wholly-owned subsidiary of the company (hereinafter referred to as "American Guoxuan") to sign relevant agreements with the Illinois government and other third parties. Up to now, Guoxuan has completed the signing of the purchase agreement of real estate assets such as land and factory buildings for this project.
113 million restricted shares of Huibo Yuntong will be listed and circulated on October 13th.
() Announcement: The number of shares issued before the company’s initial public offering is 113 million shares, accounting for 28.2315% of the company’s total share capital, and the listing date is Friday, October 13, 2023.
Puluo Pharmaceutical Co., Ltd.: The drug "Bupropion Hydrochloride Sustained Release Tablets (Ⅱ)" for the treatment of depression was approved for registration.
() Announcement: Recently, Zhejiang Puluokangyu Pharmaceutical Co., Ltd., a holding subsidiary of the company, received the Drug Registration Certificate of bupropion hydrochloride sustained-release tablets (II) approved and issued by National Medical Products Administration. It is reported that bupropion hydrochloride sustained-release tablets (II) are used to treat depression. According to the data of Minenet, the terminal sales amount of bupropion in domestic urban public hospitals, urban communities, county-level public hospitals and township health centers in 2021 and 2022 was 72.65 million yuan and 90.08 million yuan respectively.
Huali Chuangtong prompts the risk of speculation: stay away from extreme trends.
() On the evening of October 11th, the announcement of stock trading changes said that on October 11th, the company’s stock turnover rate was 47.1%, which was relatively high. Investors should pay attention to the speculation risk in the secondary market. The company is concerned that some media and stock bars and other platforms involve hot concepts in the discussion of the company’s business and a few investors spread short-term speculation about the company’s stock price. The company reminds investors to adhere to the concept of value investment, not to follow speculative thinking and stay away from extreme market trends, so as to avoid the sharp rise and fall of stock prices and cause heavy losses to personal investment.
Anke Innovation 60,675,300 restricted shares will be listed and circulated on October 13th.
() Announced that the restricted shares listed and circulated this time are the shares issued before the initial public offering, and the number of restricted shares released this time is 243 million shares, accounting for 59.72% of the company’s total share capital; The actual number of shares that can be listed and circulated is 60,675,300 shares, accounting for 14.93% of the company’s total share capital. The listing date is October 13, 2023.
Hanwang Technology: A conference will be held on the results of the large model stage of Hanwang Tiandi.
() The announcement was made on the evening of October 11th, and the results conference of Hanwang Tiandi big model stage will be held on October 12th. In addition to the staged achievements of "Hanwang Tiandi Big Model", the new series N10 of Hanwang Electronic Paper with "Hanwang Tiandi Big Model" will also be released simultaneously.
The first phase of the new high-efficiency battery project with an annual output of 12GW, a wholly-owned subsidiary of Hengdian Dongci, was put into operation.
Hengdian Dongci announced that the first phase of the 6GW new high-efficiency battery production line of the company’s wholly-owned subsidiary with an annual output of 12GW new high-efficiency battery project has been completed and gradually put into production. The company said that with the gradual release of new production capacity, it will promote the company’s photovoltaic industry to reduce costs and increase efficiency, enhance the production scale of new high-efficiency batteries, further enhance market competitiveness and profitability, and thus enhance the development potential of the company’s photovoltaic industry.
Changyuan Power: In the third quarter, the accumulated power generation was 8.713 billion kWh, a year-on-year decrease of 18.2%.
() Announcement was issued. From July 1 to September 30, 2023, the power generation enterprises affiliated to the company completed a total of 8.713 billion kWh of power generation and 8.246 billion kWh of on-grid electricity, down by 18.2% and 17.95% respectively compared with the same period of last year. The main reason for the decline is that in the third quarter of 2023, the growth rate of electricity consumption in the province declined, hydropower and new energy were issued, and the space for thermal power generation was reduced. The company’s thermal power installed capacity accounted for a relatively large proportion, and power generation decreased year-on-year.
Huali Chuangtong reminds the risk that you should not follow speculative thinking.
Beijing business today News (Reporter Ma Huanhuan) On the evening of October 11th, the demon stock Huali Chuangtong disclosed the abnormal fluctuation of stock trading and the risk warning announcement, saying that on October 11th, the company’s stock turnover rate was 47.1%, with a high turnover rate. The company reminded investors to adhere to the value investment concept, and not to follow speculative thinking and stay away from extreme market trends, so as to avoid the sharp rise and fall of the stock price and cause heavy losses to personal investment.
Huali Chuangtong said that the company was concerned that some media and stock bars and other platforms involved hot concepts in the discussion of the company’s business and that a few investors spread short-term speculation about the company’s stock price. As of October 11th, 2023, the company’s share price deviated greatly from the Growth Enterprise Market Composite Index in the same period, which was higher than the increase of companies in the same industry in the same period. Investors are requested to fully understand the trading risks in the secondary market, make prudent decisions and make rational investments.
In the secondary market, Huali Chuangtong’s share price rose sharply recently. According to statistics, during the 26 trading days from August 29th to October 11th, the cumulative increase of the company’s range reached 221.45%.
Puluo Pharmaceutical: Obtained bupropion hydrochloride sustained-release tablets (II) and obtained drug registration certificate.
On the evening of October 11th, Puluo Pharmaceutical announced that Zhejiang Puluo Kangyu Pharmaceutical, a holding subsidiary, had received the Drug Registration Certificate of Bupropion Hydrochloride Sustained-release Tablets (II) approved and issued by National Medical Products Administration. Bupropion hydrochloride sustained-release tablets (II) are used for treating depression.
() Carry out strategic cooperation with Omir to promote R&D and mass production of lightweight subframe and high-efficiency electric scroll compressor.
Xiling Power announced that the company signed the Memorandum of Strategic Cooperation Framework with Ben Omir Holding Group Co., Ltd. (referred to as "Ben Omir") on October 9, 2023, and plans to set up a joint venture company to invest 700 million yuan to develop new energy vehicle parts-lightweight subframe and high-efficiency electric scroll compressor; After the successful development of the above-mentioned projects, relevant production lines will be built, with an estimated annual output of 2 million sets of lightweight sub-frames and 500,000 sets of high-efficiency electric scroll compressors for automobiles. In the future, Ben Omir will cooperate with the Company as a strategic investor, including but not limited to subscription of private placement shares and project cooperation.
According to the announcement, the company’s strategic cooperation with Ben Omir is in line with the company’s strategic development plan, which is conducive to promoting the research and development and mass production of new products such as lightweight sub-frames of new energy automobile parts and high-efficiency electric scroll compressors, and promoting the further optimization of the company’s product structure and the development of overseas markets.
Hengmingda’s application for fixed shares was approved by Shenzhen Stock Exchange.
() Announcement: On October 11, 2023, the company received the Letter of Opinions of the Audit Center on Suzhou Hengmingda Electronic Technology Co., Ltd. applying to issue shares to a specific object issued by Shenzhen Stock Exchange. The application documents of the company to issue shares to a specific object were reviewed by the audit institution of Shenzhen Stock Exchange, and it was considered that the company met the issuance conditions, listing conditions and information disclosure requirements. The specific audit opinions were subject to the Letter of Opinions of the Audit Center, and the subsequent Shenzhen Stock Exchange will report to China Securities Supervision and Administration as required.
() Award 2 million reserved restricted shares to 29 incentive objects at a grant price of 3.93 yuan/share.
I really miss your announcement. The conditions for granting reserved restricted shares stipulated in the company’s restricted stock incentive plan for 2023 have been achieved. On October 11th, 2023, the company convened the 14th meeting of the 5th Board of Directors and the 12th meeting of the 5th Board of Supervisors, which deliberated and passed the Proposal on Granting Reserved Restricted Shares to the incentive targets of the restricted stock incentive plan for 2023, and agreed to grant 2 million reserved restricted shares to 29 incentive targets at a grant price of RMB 3.93 per share.
Harmo Science and Technology granted 9.232 million restricted shares at a price of 3.16 yuan/share.
() Announcement: The conditions for the first grant of Class I restricted shares stipulated in the "Harmo Science and Technology (Group) Co., Ltd. Restricted Stock Incentive Plan 2023 (Draft)" have been achieved. The company decided to take October 11, 2023 as the first grant date of the incentive plan and grant 9,232,000 restricted shares to 55 incentive objects meeting the conditions for the first grant at a grant price of 3.16 yuan/share.
BBK: Nine subsidiaries, including Chenzhou BBK, applied for reorganization.
() Issue an announcement, in order to simultaneously resolve the business crisis and debt risk, preserve the operating value of the company to the greatest extent, and fully protect the legitimate rights and interests of all creditors. Chenzhou BBK Investment Co., Ltd., Zhuzhou BBK Supermarket Co., Ltd., Hunan Hailong Supply Chain Management Service Co., Ltd., Changsha BBK Xingcheng Tiandi Commercial Management Co., Ltd., Hunan Teng Wan Li Supply Chain Management Co., Ltd., Liuzhou Nancheng Department Store Co., Ltd., Guilin Nancheng Department Store Co., Ltd., Luzhou BBK Yitong Commercial Co., Ltd. and Ganzhou BBK Fengda Commercial Co., Ltd. (hereinafter collectively referred to as "nine subsidiaries such as Chenzhou BBK") filed a reorganization application with the court on October 10, 2023
For example, nine subsidiaries, such as Chenzhou BBK, can implement restructuring and coordinate restructuring with BBK shares, make overall use of debt repayment resources to restructure debts, and revitalize assets and improve operating conditions by introducing investors to inject incremental resources, which can maximize the company’s core operating value and comprehensively resolve debts and operating risks. In view of the fact that there are still uncertainties about whether the nine subsidiaries such as Chenzhou BBK can be accepted by the court and whether they will enter the reorganization procedure, the specific impact on the company can only be determined after the reorganization plan is clear.
Rong Sheng Petrochemical Co., Ltd.: The amount of repurchased company shares (Phase III) reached 1 billion yuan.
() Announcement was issued. As of October 11th, 2023, the company repurchased 82,534,700 shares of the company in the third phase through the special securities account, accounting for 0.8151% of the company’s total share capital. The highest transaction price was 12.70 yuan/share, the lowest transaction price was 11.73 yuan/share, and the total transaction amount was 1.011 billion yuan (excluding transaction fees). This time, the company used its own or self-raised funds to buy back the company’s shares. At present, the total amount of repurchase funds has reached the lower limit of 1 billion yuan.
A total of 9,271,800 shares were repurchased by Potassium Sulphate International at a cost of 220 million yuan.
() Announcement: As of September 30, 2023, the company has repurchased 9,271,800 shares, accounting for 0.9979% of the company’s current total share capital. The highest transaction price is 24.85 yuan/share, the lowest transaction price is 2.225 yuan/share, and the total payment amount is 220 million yuan (excluding transaction costs).
Seymour Intelligent signed a strategic cooperation framework agreement with Good Luck United Information Company.
Saimo Intelligent announced that the company and Fujian Haoyun Lianlian Information Technology Co., Ltd. recently signed the Strategic Cooperation Framework Agreement, and the two parties intend to jointly build and optimize green and intelligent digital mines, digital logistics and digital enterprises and other related services and products.
Guoxuan Hi-Tech plans to build a lithium battery project in Illinois, USA.
Guoxuan Hi-Tech announced that the company plans to build a lithium battery project in Illinois, USA, and entrusted Guoxuan, a wholly-owned subsidiary of the company, to sign relevant agreements with the Illinois government and other third parties. The specific investment amount of the project will be determined according to the feasibility analysis and application and approval of the project. As of the date of announcement, Guoxuan has completed the signing of the purchase agreement of real estate assets such as land and factory buildings for this project.
Zhongjin Irradiation: It is planned to invest in Hefei and Changsha Comprehensive Sterilization Technology Center Project.
() On the evening of October 11th, it was announced that the company planned to invest in the project of Hefei Comprehensive Sterilization Technology Center irradiated by gold in Hefei High-tech Industrial Development Zone, mainly engaged in radiation sterilization, cleaning and disinfection of reusable medical devices modified by polymer materials and electronic components, washing of medical soft devices and linen, personnel training and technology research and development. The investment of the project is 215 million yuan during the construction period, 185 million yuan during the operation period, and the total investment of the project is about 400 million yuan. At the same time, the company plans to invest in the project of Zhongjin Irradiation Changsha Sterilization Technology Center in Ningxiang Economic and Technological Development Zone, with a total investment of about 400 million yuan.
Kaineng Health acquired 12.87% equity of Yuanneng Group for RMB 267 million.
Beijing News (Reporter Wang Kara) On October 11th, Kaineng Health announced that it had acquired 12.87% equity of Yuanneng Cell Technology Group Co., Ltd. (referred to as "Yuanneng Group") held by Shanghai Senlu and Shanghai Senba for 267 million yuan. After the completion of this acquisition, the proportion of shares held by Kaineng Health in the original energy group increased from 23.65% to 36.52%, and the original energy group remained its shareholding company.
Yuanneng Group, a shareholding company of Kaineng Health, was founded on July 16, 2014. It is mainly engaged in the research, development, production and sales of third-party storage services around cell cryopreservation, research and production of cell drugs, research and development of cell preparations, research and development of cytokine cosmetics and related automatic storage equipment. It is committed to solving the pain points and problems in the big health industry and has laid out related core enterprises and businesses. In 2022 and the first half of 2023, the revenue of the original energy group was 151 million yuan and 87.8908 million yuan respectively; The net profit was-32,208,100 yuan and 29,945,900 yuan respectively.
Yuanneng Group is an important part of Kaineng’s healthy layout and big health industry development. Up to now, Kaineng Health holds 23.6507% of its shares.
Kaineng Health said that the original energy group achieved breakeven and showed a good development momentum. The original energy group’s industry situation and its own layout are very good. At the initial stage of its establishment, it plans to plan the overall IPO listing, and it has gradually changed into cultivating the cell industry ecosystem. Under the guidance of the actual controller, the relevant business segments hire professional teams. After the business model is mature, it can plan to go public independently and introduce PE funds to accelerate. Based on the dual-energy drive development of Kaineng Health, the grand strategic layout of the health industry is strengthened, and Kaineng Health is willing to acquire the equity of Yuanneng Group.
Whereas qu jianguo, the controlling shareholder, actual controller and chairman of Kaineng Health, is the controlling shareholder and executive director of Shanghai Senlu and Shanghai Senba Executive Partner Gaosen Fund, and Zhou Bin, Chairman of the Board of Supervisors, is the shareholder and general manager of Gaosen Fund, this equity acquisition constitutes a connected transaction.
Gansu Nenghua: Capital increase of Jingmei Company, a wholly-owned subsidiary, with some assets of Jingyuan Mining Area.
Gansu Nenghua announced on the evening of October 11th that in order to improve the efficiency of asset operation, the company plans to increase the capital of Jingmei Company, a wholly-owned subsidiary, with some assets of Jingyuan Mining Area. The total assets to be used for capital contribution this time are about 12.715 billion yuan, the total liabilities are about 5.766 billion yuan, and the owner’s equity is about 6.949 billion yuan. After the capital increase is completed, the company still holds 100% equity of Jingmei Company.
The total investment of the project of Hefei Comprehensive Sterilization Technology Center to be invested by Zhongjin Irradiation is about 400 million yuan.
Zhongjin Irradiation Announcement, the company signed the Investment Cooperation Agreement with the Investment Promotion Bureau of Hefei High-tech Industrial Development Zone, and plans to invest in the construction of the Hefei Comprehensive Sterilization Technology Center Project of Zhongjin Irradiation in Hefei High-tech Industrial Development Zone, mainly engaged in irradiation sterilization, modification of polymer materials and electronic components, cleaning and disinfection of reusable medical devices, medical soft devices and linen washing, personnel training and technology research and development. The total investment of the project (including the construction period) is about 400 million yuan.
It is reported that after the completion of the project, the annual production capacity can irradiate 150,000 cubic meters of products, and at the same time, it can meet the supply of disinfection and sterilization services for 15,000 beds of surgical hard instruments and soft instruments in medical institutions.
() Pre-bid for the integrated service of investment, construction and operation of the organic waste resource comprehensive treatment center in Tongzhou District, Beijing.
Langkun Environment released an announcement. Recently, Beijing Engineering Construction Trading Information Network released the "Announcement of Successful Candidates for the Construction of Integrated Services for Investment, Construction and Operation of Tongzhou District Organic Waste Resource Comprehensive Treatment Center". The company is the successful candidate for the above-mentioned projects, with a total investment of about 1.678 billion yuan, of which the general contracting cost of construction is 1.34 billion yuan.
The company is a leading enterprise in the field of organic solid waste treatment in China. The bid-winning integrated service project of investment, construction and operation of the organic waste comprehensive treatment center in Tongzhou District of Beijing is another major benchmark project of the company following Shenzhen, Guangzhou and Zhongshan, and it is an important symbol of the further expansion and extension of the comprehensive treatment business of organic solid waste on the basis of the original vast territory, which will have a positive impact on the company’s future business performance and will not affect the company’s operational independence.
Yingtong Communication’s wholly-owned subsidiary obtained the invention patent certificate.
On the evening of October 11th, () announced that Dongguan Kailai Electronics Co., Ltd. and Dongguan Yingtong Wire Co., Ltd., wholly-owned subsidiaries of Yingtong Communication Co., Ltd., recently obtained an invention patent certificate issued by China National Intellectual Property Administration (patent number: ZL201811264557.0). The patent name of this invention is "An Air Pressure Protection Device for Preventing Glue Backflow", and the inventors are Song Minghua, Zuo Guiming, You Kaikai and Dong Wang. The announcement date of authorization is October 10, 2023, and the patent right period is 20 years from the application date.
() It is proposed to withdraw from the 25.81% equity of Huai ‘an Aoyang Shunchang by capital reduction, with a capital reduction consideration of 520 million yuan.
Mulinsen announced that according to the company’s strategic development needs, in order to further optimize the company’s resource allocation and capital use arrangements and improve the efficiency of capital use, the company plans to withdraw from the 25.81% equity of Huai ‘an Aoyang Shunchang Optoelectronic Technology Co., Ltd. with a capital reduction consideration of 520 million yuan through directional capital reduction. After the capital reduction is completed, the company will no longer hold the equity of Huai ‘an Aoyang Shunchang.
CICC Irradiation plans to build Changsha Sterilization Technology Center with Chutian Technology with a total investment of about 400 million yuan.
According to the announcement of Zhongjin Irradiation, the company signed the Contract for the Project of Zhongjin Irradiation Changsha Sterilization Technology Center to Settle in the National Ningxiang Economic and Technological Development Zone with the Management Committee of Ningxiang Economic and Technological Development Zone and () Co., Ltd. ("Chutian Technology", 300358.SZ), and plans to invest in the project of Zhongjin Irradiation Changsha Sterilization Technology Center in Ningxiang Economic and Technological Development Zone. The total investment of the project (including the construction period) is about 400 million yuan.
According to the announcement, the company plans to jointly establish a joint venture company with Chutian Technology in Ningxiang Economic and Technological Development Zone as the main body of the project implementation. The name of the joint venture company is planned to be Zhongjin Health Technology (Changsha) Co., Ltd., with a registered capital of 80 million yuan, of which Zhongjin Irradiation holds 91% of the shares, with a capital contribution of 72.8 million yuan; Chutian Technology holds 9% of the shares with a capital contribution of 7.2 million yuan.
CICC Irradiation plans to build Changsha Sterilization Technology Center with Chutian Technology with a total investment of about 400 million yuan.
Announcement of Zhongjin Irradiation, the company signed the Contract for the Project of Zhongjin Irradiation Changsha Sterilization Technology Center to Settle in the National Ningxiang Economic and Technological Development Zone with the Management Committee of Ningxiang Economic and Technological Development Zone and Chutian Technology Co., Ltd. ("Chutian Technology", 300358.SZ), and plans to invest in the project of Zhongjin Irradiation Changsha Sterilization Technology Center in Ningxiang Economic and Technological Development Zone. The total investment of the project (including the construction period) is about 400 million yuan.
According to the announcement, the company plans to jointly establish a joint venture company with Chutian Technology in Ningxiang Economic and Technological Development Zone as the main body of the project implementation. The name of the joint venture company is planned to be Zhongjin Health Technology (Changsha) Co., Ltd., with a registered capital of 80 million yuan, of which Zhongjin Irradiation holds 91% of the shares, with a capital contribution of 72.8 million yuan; Chutian Technology holds 9% of the shares with a capital contribution of 7.2 million yuan.
Sophia’s application to issue shares to a specific target was approved by Shenzhen Stock Exchange.
() Announcement was issued. On October 11, 2023, the company received the Letter of Opinions of the Audit Center on Sophia Home Furnishing Co., Ltd. applying for issuing shares to specific targets issued by the Listing Audit Center of Shenzhen Stock Exchange. The listing audit institution of Shenzhen Stock Exchange has audited the application documents for the company to issue shares to a specific target, and found that the company meets the requirements for issuance, listing and information disclosure. Subsequently, Shenzhen Stock Exchange will report to China Securities Regulatory Commission for relevant registration procedures as required.
The issue of the company’s shares to a specific target needs to be approved by the China Securities Regulatory Commission before it can be implemented. There is still uncertainty about whether or not the China Securities Regulatory Commission can finally approve the registration decision and its time.
BBK: Nine subsidiaries, including BBK Chenzhou, have applied to the court for reorganization.
BBK announced on the evening of October 11th that in order to simultaneously resolve the business crisis and debt risk and preserve the company’s operational value to the greatest extent, The wholly-owned subsidiaries of the company, Chenzhou BBK Investment Co., Ltd., Zhuzhou BBK Supermarket Co., Ltd., Hunan Hailong Supply Chain Management Service Co., Ltd., Changsha BBK Xingcheng Tiandi Commercial Management Co., Ltd., Hunan Teng Wan Li Supply Chain Management Co., Ltd., Liuzhou Nancheng Department Store Co., Ltd., Guilin Nancheng Department Store Co., Ltd., Luzhou BBK Yitong Commercial Co., Ltd. and Ganzhou BBK Fengda Commercial Co., Ltd. (collectively referred to as "nine subsidiaries such as Chenzhou BBK") filed reorganization applications with the court on October Whether the reorganization application can be accepted by the court and whether it will enter the reorganization procedure is still uncertain.
Langkun Environment: Pre-bid for Tongzhou District Organic Waste Resource Comprehensive Treatment Center Project.
Langkun Environment announced on the evening of October 11th that recently, Beijing Engineering Construction Trading Information Network released the "Announcement of Successful Candidates for the Construction of Integrated Services for Investment, Construction and Operation of Organic Waste Resource Comprehensive Treatment Center in Tongzhou District", and the company was the successful candidate for this project, with a total investment of about 1.678 billion yuan, of which the total construction contract cost was 1.34 billion yuan.
Guangdian Express intends to transfer 72% equity of Digital Finance Innovation Institute, focusing on the main business development.
Guangdian Express announced that in order to better focus on the development of its main business, the company plans to transfer 72% equity of Digital Finance Innovation Institute to Guangzhou Radio Group Co., Ltd. ("Radio Group"), and the transfer price is 18 million yuan based on the evaluation results. After the completion of this equity transfer, the company no longer holds the equity of Digital Finance Innovation Institute.
Zhu Song Zhao Weixing, CEO of Hualin Securities, resigned for personal reasons.
() It was announced that Zhao Weixing applied to resign as CEO and chairman of the Executive Committee for personal reasons, and Guan Xiaobin, the company’s chief financial officer and chief risk officer, resigned for personal reasons. The board of directors decided to hire Zhu Song as CEO and chairman of the Executive Committee and concurrently serve as the company’s chief financial officer. At the same time, Zhang Dawei, the compliance director, was appointed as the chief risk officer. Hualin Securities said that during his tenure, Zhao Weixing actively promoted the transformation of the company’s technology and finance, and the board of directors of the company expressed heartfelt thanks for his contribution. According to the resume, Zhu Song, the new CEO, was born in 1978 and has more than 20 years of practical experience in the management of financial institutions. He has worked in ICBC, Pudong Development Bank, Dongzheng Futures, Oriental Financial Holdings, (), etc., participated in the preparation of the precious metals business department of ICBC Head Office and took the lead in preparing the asset management department of Pudong Development Bank, and formed a professional market judgment and exhibition concept among various assets.
Haichen Holdings Sun Company plans to acquire 100% equity of Kunshan Mengli to strengthen its business capability in the field of automation.
() Announcement: Jiangsu Haikunmeng Intelligent Technology Co., Ltd. (hereinafter referred to as "Haikunmeng"), the holding company of the company, plans to acquire 100% equity of Mengli Automation (Kunshan Mengli) Co., Ltd. (hereinafter referred to as "Kunshan Mengli") with its own funds in cash at a purchase price of 180 million yuan (including tax). After the acquisition is completed, Kunshan Mengli will become the holding company of the company and be included in the scope of the company’s consolidated statements.
According to the announcement, the target company is one of the representative enterprises in the field of intelligent automation. It has rich technical accumulation in the field of automation equipment and integration, and has long served the head customers in the fields of semiconductors, panels, smart factories and intelligent logistics at home and abroad. It can provide customers with smart factories and automation solutions, and has a good product reputation and brand reputation.
It is reported that this acquisition of the target company will help to further strengthen the business capability and technical level of Haichen Co., Ltd. in the field of automation. In the future, it will be able to provide automation equipment and integration services to advanced manufacturing customers in a wider range of fields, including semiconductor and photoelectric panels, which will have a good synergy with the company’s original automation business and further enhance the company’s core competitiveness in this field.
Haichen shares: The holding company plans to acquire 100% equity of Kunshan Mengli for 180 million yuan.
Haichen announced on the evening of October 11th that in order to speed up the company’s automation business, Jiangsu Haikunmeng Intelligent Technology Co., Ltd., the holding sun company, plans to acquire 100% equity of Mengli Automation (Kunshan Mengli) Co., Ltd. (hereinafter referred to as "Kunshan Mengli") in cash at a purchase price of 180 million yuan. Kunshan Mengli has rich technical accumulation in the field of automation equipment and integration, and has long served the leading customers in the fields of semiconductors, panels, smart factories and intelligent logistics at home and abroad, and can provide customers with smart factories and automation solutions.
Haichen shares hired Li Shipeng as the chief scientist.
Haichen shares announced that the company recently hired Academician Li Shipeng as the company’s chief scientist.
Xiling Power: Signed a Memorandum of Strategic Cooperation Framework with Ben Omir.
Xiling Power announced on the evening of October 11th that the company signed the Memorandum of Strategic Cooperation Framework with Ben Omir Holding Group Co., Ltd. (referred to as "Ben Omir") on October 9th, and plans to set up a joint venture company to invest 700 million yuan to develop new energy automobile parts-lightweight subframe and high-efficiency electric scroll compressor; After the successful development of the above-mentioned projects, relevant production lines will be built, with an estimated annual output of 2 million sets of lightweight sub-frames and 500,000 sets of high-efficiency electric scroll compressors for automobiles. In the future, Ben Omir will cooperate with the company as a strategic investor, including subscription of private placement shares and project cooperation. The company’s strategic cooperation with Ben Omir is conducive to further optimizing the company’s product structure and opening up overseas markets.
Xuan Ya International Limited Stock Application was approved by Shenzhen Stock Exchange.
() Announcement: On October 11, 2023, the company received the Letter of Opinions from the Audit Center of Xuan Ya International Marketing Technology (Beijing) Co., Ltd. on the application for issuing shares to specific targets, which was issued by the Audit Center of Shenzhen Stock Exchange. The audit institution for the issuance and listing of Shenzhen Stock Exchange has audited the application documents for the company to issue shares to a specific target, and found that the company meets the requirements for issuance, listing and information disclosure. Subsequently, Shenzhen Stock Exchange will report to China Securities Regulatory Commission for relevant registration procedures as required.
Luxin Capital, the major shareholder of Sanyuan Bio, reduced its shareholding by 3.35% at the expiration of the reduction period.
() Announcement: Luxin Capital, a shareholder holding more than 5% of the company’s shares, has reduced its holdings by 6.78 million shares, accounting for 3.351% of the total share capital.
OCT plans to sell the hotel series assets of Shanghai Suhewan Project.
The Beijing News (Reporter Zhang Jian) On October 11th, OCT (Asia) Holdings Co., Ltd. announced that OCT Shanghai Land, an indirect subsidiary, plans to sell some assets of the Shanghai Suhewan project through public listing on the Beijing Equity Exchange.
According to the announcement, the above-mentioned sales assets are a series of assets of Suhewan Project Hotel, located at No.5–8, No.11 and No.16–18, Lane 108, Shanxi North Road, Jing ‘an District, Shanghai; No.96, 98, 112, 116, 120 and 126 North Shanxi Road; No.673, 677 and 681 Tiantong Road; No.17 and No.23, North Henan Road; 1-3 floors and basement corridor of No.33, 39 and 51 North Henan Road; Floor 1-2, No.468 North Suzhou Road, with a building area of about 23,200 square meters. In addition, there are 6924.68 square meters of hotel facilities and supporting rooms on the 1st and 2nd floors underground of T1 building, and 5128.80 square meters of 88 underground parking spaces.
According to the announcement, the reserve price of the above-mentioned target is not less than 2.43 billion yuan. Assuming that the proposed sale is completed at the lowest price, OCT is expected to generate revenue of about 57 million yuan.
Fudan Fuhua plans to sell real estate in the core area of Shanghai for 31.05 million yuan.
On the evening of October 11th, Shanghai () Technology Co., Ltd. (hereinafter referred to as "Fudan Fuhua") announced that its wholly-owned subsidiary, Shanghai Krupp Control System Co., Ltd. (hereinafter referred to as "Krupp"), planned to sell the real estate in the core area of Shanghai with an estimated value of 31,053,100 yuan.
Fudan Fuhua said that the sale of real estate meets the needs of the company’s production and operation development, can revitalize the company’s assets, effectively withdraw funds, has a positive impact on the company’s financial situation, has no adverse impact on the company’s normal production and operation, and is in the interest of all shareholders and the company.
According to the announcement, upon appraisal, the office real estate in Rooms 2006 and 2007, No.333 Huaihai Middle Road, Huangpu District (with a total construction area of 4,487.3 square meters) entrusted by Krupp has a book value of 7,652,600 yuan on the benchmark date and an appraised value of 31,053,100 yuan.
"Some non-real estate listed companies hold some real estate projects, and selling more at this time is to focus their funds and energy on the main business. The behavior of such enterprises also represents the mentality of many real estate companies. Now the real estate industry is facing adjustment, and listed companies are also worried about the market outlook. " Yan Yuejin, research director of Yiju Research Institute, told the Securities Daily reporter.
In addition, from the financial data, Fudan Fuhua’s performance pressure is not small. In the first half of 2023, the operating income of Fudan Fuhua decreased by 6.43% year-on-year, and the net profit loss attributable to shareholders of listed companies was about 17.18 million yuan.
In addition to Fudan Fuhua, () announced on the evening of September 15th that the company intends to apply to Beijing Equity Exchange to re-list the 100% equity project of Shunxin Jiayu, and adjust the transfer reserve price to 2.789 billion yuan. As a wholly owned subsidiary of Shunxin Agriculture, Shunxin Jiayu’s main business is real estate development.
On September 20th, () announced that it planned to publicly list and sell its 20 real estates in Contemporary International Plaza, No.177 Dongchang Road, Liaocheng Economic Development Zone, Shandong Province, with an estimated value of 12,444,300 yuan in the Property Rights Exchange Center.
Guangdian Express intends to list and transfer the equity of two subsidiaries, saying that it is beneficial to withdraw funds and focus on the main business.
On the evening of October 11th, Guangdian Express issued two announcements about the transfer of the equity of subsidiaries. One was to publicly list and transfer the 51% equity of Jiangsu Huitong Jinke Data Co., Ltd. (hereinafter referred to as "Huitong Jinke"), and the total listing and transfer price was not less than about 181.1 million yuan. Second, the company intends to transfer 72% equity of Digital Finance Innovation Institute to Guangzhou Radio Group Co., Ltd. (hereinafter referred to as "Radio Group") at a transfer price of 18 million yuan.
"The equity transfer of the two subsidiaries is conducive to the company’s capital withdrawal and better focus on the development of its main business." A related person from the Board of Directors of Radio and Television Express told the Securities Daily reporter.
Proposed transfer of two subsidiaries
According to public information, Guangdian Express’s main business covers the fields of intelligent finance, transportation, public safety, government affairs and convenience, large-scale travel, new retail, etc. It is a leading provider of artificial intelligence solutions in China.
It is reported that in 2016, Guangdian Express used its own funds to subscribe for about 52.04 million shares of Huitong Jinke by issuing shares in a targeted way. The subscription price per share was 3.2 yuan, and the subscription amount was about 166.5 million yuan. In total, it held 51% equity of Huitong Jinke, became its controlling shareholder, and cut into the outsourcing service business of bank call center. According to public information, the net profit of Huitong Jinke in the first half of 2023 was 7,037,500 yuan.
Guangdian Express believes that since the acquisition, Huitong Jinke’s performance has continuously failed to meet expectations, and its bank call center outsourcing service business has little correlation with the company’s artificial intelligence high-tech main business. Therefore, equity transfer is conducive to withdrawing funds and better focusing on the main business.
At the same time, in 2021, Guangdian Express and Guangzhou Urban Renewal Group Co., Ltd. and other five companies jointly funded the establishment of Digital Finance Innovation Institute with a registered capital of 50 million yuan, of which Guangdian Express contributed 36 million yuan with its own funds, accounting for 72% of the registered capital. Digital Finance Innovation Institute paid in registered capital of 25 million yuan for the first time, of which the company paid in 18 million yuan in the first phase.
"The above-mentioned equity transfer will help to give full play to the resource advantages of the digital finance industry of Radio Group and better enhance the strategic value of the Digital Finance Innovation Institute; At the same time, it is conducive to the company to realize the return of funds and better focus on the development of its main business. " Guangdian Express said.
Layout model and payment service
According to the record of investor relations activities of Radio and Television Express, the company has continuously strengthened its digital technology capabilities, released aiCoreSystemV3.0, built a big model of the industry "Wangdao", created a new paradigm of AI+ scenarios, boosted the "last mile" of the big model industry, and provided strong AI capability support and intelligent solutions for smart government, smart banking, smart auditing, smart state-owned assets and other business fields.
In addition, Guangdian Express previously acquired 90.01% equity of CICC for 266 million yuan to pay for the business and further strengthen the company’s layout in the fields of banking and government financial technology.
"Guangdian Express has obtained a third-party payment license by acquisition. CICC Payment has accumulated profound experience in the field of B2B payment, has the multi-scenario comprehensive payment capability of Internet payment product line, and has formed a unique industrial chain comprehensive payment product system. After the company’s acquisition is completed, it will be able to provide customers with capital payment solutions, further realizing the data closed loop in various scenarios and platforms. " Xia Qingying, a researcher in the computer industry of Wanlian Securities, told the Securities Daily reporter.
"In the domestic financial market, the company continued to consolidate the leading edge of smart equipment business, and seized opportunities such as financial innovation, digital RMB promotion, and intelligent outlets to further enhance market share; In overseas markets, the company will increase the expansion of innovative businesses such as smart retail and smart buildings, and promote mature financial technology innovation solutions in the global market. " The relevant person of the above-mentioned Guangdian Express Secretary Office said.
In the event of fixed increase, the actual controller who promised the subscriber the guaranteed income was warned.
On the evening of October 11th, Jingu Co., Ltd. issued an announcement. On October 10th, the controlling shareholders, actual controllers Sun Fengfeng, Sun Jinguo and Sun Liqun (hereinafter referred to as "actual controllers") received the Decision on Taking Measures to Issue Warning Letters to Sun Fengfeng, Sun Jinguo and Sun Liqun issued by Zhejiang Supervision Bureau of China Securities Regulatory Commission.
The announcement shows that during the non-public offering of shares by Jingu in 2017, the actual controller signed relevant agreements with the subscribers of non-public offering of shares such as Jiutai Fund Management Co., Ltd., and agreed to guarantee the bottom income.
Regarding the above-mentioned behaviors, many insiders told the Securities Daily reporter that the matters that the subscribers agreed to guarantee the guaranteed income should be submitted to the shareholders’ meeting for consideration, and the behavior of listed companies has been suspected of violating information disclosure. Moreover, this behavior will infringe upon the legitimate rights and interests of other shareholders.
Shen Meng, executive director of chansons Capital, told the Securities Daily reporter: "It is illegal to agree on the guaranteed income to the subscribers. On the one hand, such guaranteed income makes it possible for the fixed shares to be’ clear shares and real debts’. On the other hand, providing guaranteed income to some shareholders is unfair to other shareholders and violates the consistency of the same shares and rights of listed companies."
In view of the fact that the above-mentioned behavior of the actual controller of Jingu shares violates Article 17 of the Measures for the Administration of Securities Issuance and Underwriting (Order No.121 of the CSRC) and Article 2 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of the CSRC). Zhejiang Supervision Bureau decided to issue warning letters to Sun Fengfeng, Sun Jinguo and Sun Liqun respectively, and record them in the integrity files of the securities and futures markets.
Lawyer Wang Zhibin of Shanghai Minglun Law Firm told the Securities Daily reporter that important matters of listed companies have strict legal provisions in internal deliberation and information disclosure. In the process of private placement, the promise of guaranteed income to the subscribers constitutes a substantial modification of the issuance plan. These matters are major matters and should be submitted to the shareholders’ meeting for deliberation and information disclosure in a timely manner in accordance with the law. "If it is a commitment made by the issuer’s management in the name of the listed company without deliberation at the shareholders’ meeting, In addition, the issuer did not disclose the issuance plan truthfully and completely, which constituted an information disclosure violation. "
Jingu shares said that after receiving the warning letter, the actual controller will submit a written rectification report to Zhejiang Securities Regulatory Bureau as soon as possible as required. "Attaching great importance to the problems pointed out in the warning letter, we will fully learn lessons, earnestly strengthen the study of securities laws and regulations, raise the awareness of standardized operation, and resolutely follow the requirements of information disclosure standards of listed companies; At the same time, the controlling shareholder and actual controller of the company will earnestly fulfill their due diligence obligations, urge the company to standardize its operation, prevent the above-mentioned matters from happening again, continuously improve the quality of information disclosure, safeguard the interests of the company and all shareholders, and promote the healthy, stable and sustainable development of the company. "
Over the rainbow shares: Shareholder Wulong Company reduced its shareholding by 32,655,700 shares.
China Economic Net, Beijing, October 12 th, over the rainbow announced last night that the company disclosed the "Pre-disclosure Announcement on Shareholding Reduction by Shareholders Holding More than 5% (2023-015)" on March 18, 2023, and Wulong Trading Co., Ltd. (hereinafter referred to as "Wulong Company") holds 191,908,453 shares of the company (accounting for 16.42% of the company’s total share capital)
Recently, the company received the Letter of Notice on the Expiration of the Plan to Reduce the Shares of over the rainbow Shuke Commercial Co., Ltd. issued by Wulong Company. As of October 10, 2023, the above-mentioned plan has expired. Wulong Company reduced its holdings by a total of 32,655,700 shares, with a reduction ratio of 2.80%.
Before this reduction, Wulong Company held 191,908,453 shares of over the rainbow, accounting for 16.42% of the total share capital; After this reduction, Wulong Company holds 159,252,753 shares of over the rainbow, accounting for 13.62% of the total share capital.
